Page last updated: 2024-11-03

propofol and Non-alcoholic Fatty Liver Disease

propofol has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, Z1
Xiang, S1
Pan, C1
Jiang, C1
Bao, S1
Shangguan, W1
Zeng, R1
Li, J1
Lian, Q1
Wu, B1

Other Studies

1 other study available for propofol and Non-alcoholic Fatty Liver Disease

ArticleYear
The excitatory transmission from basolateral nuclues of amygdala to nucleus accumbens shell regulates propofol self-administration through AMPA receptors.
    Addiction biology, 2023, Volume: 28, Issue:8

    Topics: Amygdala; Animals; Humans; Male; Non-alcoholic Fatty Liver Disease; Nucleus Accumbens; Propofol; Rat

2023